Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2023-11-07 00:00:00 ET · period of report 2023-11-03 · accession 0001415889-23-014841 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-11-07 | 2023-11-03 | KNSA | Levy Richard S | Dir | M - OptEx | — | +2,777 | 7,777 | +56% | — |
| D | 2023-11-07 | 2023-11-03 | KNSA | Levy Richard S | Dir | M - OptEx | $0.00 | -2,777 | 0 | -100% | $0 |
| D | 2023-11-07 | 2023-11-03 | KNSA | Levy Richard S | Dir | A - Grant | $0.00 | +2,777 | 2,777 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2023-11-03 | M | A | 2,777 | — | 7,777 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Derivative | Restricted Share Units | 2023-11-03 | M | D | 2,777 | $0.00 | 0 | D | — · — to — | 2,777 Class A Common Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs. |
| 3 | Derivative | Restricted Share Units | 2023-11-03 | A | A | 2,777 | $0.00 | 2,777 | D | — · — to — | 2,777 Class A Common Shares | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vested immediately upon grant on November 3, 2023; there was no expiration date for the RSUs. |